Joint side effects from immunotherapy in melanoma patients
Part of Cancer, Skin clinical trials.
This study looks at whether a type of cancer treatment called immune checkpoint inhibitors can cause side effects in your joints or muscles. You will have an ultrasound and a physical exam to check for these problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage IIB, IIC, III, or IV melanoma and are about to start a treatment called an immune checkpoint inhibitor.
- You have not been treated with an immune checkpoint inhibitor before.
- You do not have a long-term joint disease like arthritis or gout.
- You do not have a condition that affects your whole body and can involve your joints, such as inflammatory bowel disease.
- You are 18 years old or older and able to give your consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with advanced melanoma (a serious skin cancer) feel during treatment with immunotherapy. It aims to better understand the symptoms they experience, so doctors can help manage them.
This study looks at whether physical activity can help reduce side effects from immunotherapy in people with melanoma. You may join if you are starting a certain type of immunotherapy for melanoma.
This study is for people whose immunotherapy (a type of cancer treatment) caused joint pain, swelling, or muscle stiffness. Researchers want to talk to you about how these side effects have affected your life, so they can better understand and help others in the future.
This study looks at long-term side effects in people who received immunotherapy for advanced melanoma and have had their cancer controlled for at least 3 years. Researchers want to understand how these treatments affect patients years later.
This study looks at side effects from immune checkpoint inhibitors in people with solid tumors. It aims to understand why side effects happen and who might be at risk, so doctors can better manage them.
This study looks at how side effects happen in people receiving immune checkpoint inhibitor immunotherapy for solid cancers. It uses multiple types of tests to better understand these toxicities and may help improve safety and care in the future.
Hear when a new Melanoma Stage III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.